Search / Trial NCT06229925

Effects of Transcranial Direct Current Stimulation Versus Sham in Subacromial Pain Syndrome

Launched by UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE · Jan 26, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Transcranial Direct Current Stimulation Neuromodulation Pain In The Shoulder Chronic Pain Treatment

ClinConnect Summary

This clinical trial is studying a treatment called Transcranial Direct Current Stimulation (tDCS) to see how it affects people with subacromial pain syndrome, which is a type of shoulder pain that can make daily activities difficult. The researchers want to find out if tDCS can help reduce pain levels, improve function, enhance quality of life, and increase muscle strength and range of motion in the shoulder.

To participate in this study, individuals must be experiencing pain in one shoulder for at least three months, with a pain score of 3 or higher on a scale of 0 to 10. They should also have a certain level of disability related to their shoulder pain, as measured by a specific questionnaire. However, those who have had shoulder surgery, certain medical conditions, or are currently pregnant cannot take part in this trial. Participants will receive either the active tDCS treatment or a placebo (sham) treatment and will be closely monitored throughout the study to assess the effects on their pain and shoulder function. If you or someone you know is dealing with this type of shoulder pain, this trial may offer a potential new option to consider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Unilateral pain in one shoulder
  • Pain level ≥ 3 on the Numerical Pain Scale (END), at rest, for at least 3 months
  • No previous treatment with tDCS
  • Present graded disability on the DASH questionnaire (\> 15 points)
  • At least three positive tests, among the five indicated below: Neer, Hawkins, Jobe, Patte or painful abduction arch.
  • Exclusion Criteria:
  • Indication for surgical repair and/or history of shoulder surgery
  • Shoulder fracture and/or dislocation
  • Partial or total rupture of one of the rotator cuff tendons and/or the long head of the biceps
  • Fibromyalgia
  • History of epilepsy
  • Panic syndrome
  • Implantable devices in the skull
  • Significant neurological or psychiatric diseases
  • Severe cardiopulmonary, renal and hepatic diseases
  • Current pregnancy.

Trial Officials

Vinícius Dantas, Esp

Principal Investigator

Universidade Federal do Rio Grande do Norte

About Universidade Federal Do Rio Grande Do Norte

The Universidade Federal do Rio Grande do Norte (UFRN) is a prestigious Brazilian institution dedicated to advancing education, research, and innovation in various fields, including health sciences. As a clinical trial sponsor, UFRN leverages its robust academic and research capabilities to contribute to the development of effective medical interventions and therapies. The university fosters collaborative partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring that clinical trials conducted under its auspices adhere to the highest ethical standards and regulatory requirements. UFRN is committed to enhancing public health outcomes through rigorous scientific inquiry and the translation of research findings into clinical practice.

Locations

Natal, Rn, Brazil

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0